2020
DOI: 10.1002/adtp.201900187
|View full text |Cite
|
Sign up to set email alerts
|

A Reactive Prodrug Ink Formulation Strategy for Inkjet 3D Printing of Controlled Release Dosage Forms and Implants

Abstract: In article number 1900187 by Clive J. Roberts, Ricky D. Wildman and co‐workers report an entirely new approach to formulating and controlling drug release from 3D printed systems/implants. This approach allows for hierarchical control over release, by exercising control over composition of a printed system over multiple length scales through molecular to macroscopic.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4
2
1
1

Relationship

5
3

Authors

Journals

citations
Cited by 19 publications
(12 citation statements)
references
References 43 publications
0
11
0
Order By: Relevance
“…A trial printing of the remaining materials was then conducted to determine the reliability of printing and whether the materials would cure on our printing configuration. From this we selected two materials that showed the greatest promise for successful printing and proceeded to optimise the formulations ready for scale up [25][26][27][28] ( Supplementary Table S1): tricyclo[5.2.1.02,6]decanedimethanol diacrylate (TCDMDA) and ethylene glycol dicyclopentenyl ether acrylate (EGDPEA). Sixteen formulations were then investigated where the photoinitiator and the candidate monomers were combined covering a breadth of utility in different environments and potential reaction speeds (Supplementary Table S2) as both could influence the product performance [22,[29][30][31] .…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…A trial printing of the remaining materials was then conducted to determine the reliability of printing and whether the materials would cure on our printing configuration. From this we selected two materials that showed the greatest promise for successful printing and proceeded to optimise the formulations ready for scale up [25][26][27][28] ( Supplementary Table S1): tricyclo[5.2.1.02,6]decanedimethanol diacrylate (TCDMDA) and ethylene glycol dicyclopentenyl ether acrylate (EGDPEA). Sixteen formulations were then investigated where the photoinitiator and the candidate monomers were combined covering a breadth of utility in different environments and potential reaction speeds (Supplementary Table S2) as both could influence the product performance [22,[29][30][31] .…”
Section: Resultsmentioning
confidence: 99%
“…printer nozzles. In order to maximise printability, inks were sealed and stored at 4°C overnight to help release any bubbles generated during preparation [27] .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In recent decades, 3D printing has been recognised by many to be an answer to this call and the future of polypharmacy [12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29]. The possibility to mass-produce personalised components without substantially increasing production time or costs makes 3D printing an attractive proposition [12][13][14].…”
Section: Introductionmentioning
confidence: 99%
“…In principle, material composition can be varied on a voxel or droplet basis. which opens the possibility of a next generation of 3DP that allows the user to produce devices with spatially distributed, customizable material functionalities in a cost-effective manner [10][11][12][13][14] . This paper sets out to develop a platform by which MM-IJ3DP can be used to create bespoke devices with tuneable, spatially varying mechanical performance, whilst incorporating and retaining cell-instructive functions -in this case resistance to bacterial biofilm formation.…”
Section: Introductionmentioning
confidence: 99%